Clinical Trial: Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06394063) titled 'Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients' on April 28.

Brief Summary: This study is a randomized, double-blind, placebo-controlled single-center clinical trial. The aim of this study is to investigate the efficacy and safety of low-dose telitacicept for prevention of flares in SLE patients with low disease activity.

Study Type: Interventional

Condition: Systemic Lupus Erythematosus

Intervention: * Biological: Telitacicept

Telitacicept 160 mg SC every other week

* Drug: Placebo

Placebo to Telitacicept

Recruitment Status: Not Yet Recruiting

Published by HT Digital Content Services with permiss...